SCHEMBL29950690

SCHEMBL29950690

CCOC(=O)c1ccc(B(O)O)cc1F

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CA12 O43570 2/20 0.47
CA1 P00915 2/20 0.47
CA2 P00918 2/20 0.47
CA7 P43166 2/20 0.47
CA9 Q16790 2/20 0.47
CA14 Q9ULX7 2/20 0.47
TSHR P16473 2/20 0.47
NPC1 O15118 2/20 0.45
PKM P14618 1/20 0.44
ALDH1A1 P00352 2/20 0.41
HSD17B10 Q99714 1/20 0.41
L3MBTL1 Q9Y468 3/20 0.41
MEN1 O00255 1/20 0.41
KMT2A Q03164 1/20 0.41
ATM Q13315 1/20 0.41
POLB P06746 1/20 0.41
SMN1; SMN2 Q16637 1/20 0.41
TDP1 Q9NUW8 1/20 0.41
JMJD6 Q6NYC1 1/20 0.41
LMNA P02545 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL763540 1.00 CA12 (0.47) CA12CA1CA2CA7CA9
SCHEMBL473842 0.88 TSHR (0.47) CA12CA1CA2CA7CA9
SCHEMBL28616192 0.85 TSHR (0.53) TSHRALDH1A1HSD17B10L3MBTL1POLB
SCHEMBL28855354 0.84 CA12 (0.50) CA12CA1CA2CA7CA9
SCHEMBL28624131 0.83 TSHR (0.55) TSHRNPC1ALDH1A1HSD17B10L3MBTL1
SCHEMBL363322 0.82 CA1 (0.43) CA12CA1CA2CA7CA9
SCHEMBL29954716 0.81 CYP4F2 (0.49) CA12CA1CA2CA7CA9
SCHEMBL15286075 0.81 CYP4F2 (0.49) CA12CA1CA2CA7CA9
SCHEMBL4975437 0.81 ALDH1A1 (0.57) CA12CA1CA2CA7CA9
SCHEMBL367075 0.80 TSHR (0.57) CA12CA1CA2CA7CA9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2024226875-A2 COMPOUNDS, COMPOSITIONS AND METHODS FOR ATTENUATION OF MAMMALIAN TRANSLATION OF C-MYC OR N-MYC PROTEINS OF THE MYC PROTO-ONCOGENE FAMILY OF BHLH TRANSCRIPTION FACTORS INITIAL THERAPEUTICS, INC. (US) 2024-10-31 WO disclosed
CN-116887827-A Compounds and methods for modulating FXR 拓臻制药公司 2023-10-13 CN disclosed
US-20220340893-A1 BI-FUNCTIONAL COMPLEXES AND METHODS FOR MAKING AND USING SUCH COMPLEXES NUEVOLUTION A/S (DK) 2022-10-27 US disclosed